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ABSTRACT
Timely removal of oxidatively damaged proteins is crit-
ical for cells exposed to oxidative stresses; however,
cellular mechanism for clearing oxidized proteins is not
clear. Our study reveals a novel type of protein modifi-
cation that may play a role in targeting oxidized proteins
and remove them. In this process, DSS1 (deleted in split
hand/split foot 1), an evolutionally conserved small
protein, is conjugated to proteins induced by oxidative
stresses in vitro and in vivo, implying oxidized proteins
are DSS1 clients. A subsequent ubiquitination targeting
DSS1-protein adducts has been observed, suggesting
the client proteins are degraded through the ubiquitin-
proteasome pathway. The DSS1 attachment to its clients
is evidenced to be an enzymatic process modulated by
an unidentified ATPase. We name this novel protein
modification as DSSylation, in which DSS1 plays as a
modifier, whose attachment may render target proteins a
signature leading to their subsequent ubiquitination,
thereby recruits proteasome to degrade them.
KEYWORDS DSS1, shfm1, free radicals, oxidative
stress, proteasome, protein modification, DSSylation
INTRODUCTION
In normal cells, free radicals act as signaling molecules that
contribute to the maintenance of homeostasis (Dröge, 2002).
They are mainly derived from oxygen (reactive oxygen
species (ROS)) and nitrogen (reactive nitrogen species
(RNS)), or are formed from biomolecules interacting with
ROS or RNS, e.g. protein hydroperoxides (Devasagayam
et al., 2004; Li and Wogan, 2005; Luperchio et al., 1996).
Under normal physiological conditions, cells are equipped
with mechanisms for the removal of intracellular free radicals
when they begin to exceed tolerable levels (Matés, 2000).
However, in cells exposed to environmental stressors, such
as heat shock, chemicals, ultraviolet (UV) radiation, and
ionizing radiation (IR) (Schröder and Krutmann, 2005), or in
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cells under certain pathophysiological conditions (Pala and
Gürkan, 2008), the resulting high ROS levels overcome
intracellular defenses and can cause intracellular oxidative
stress. In these stressed cells, biomolecules are susceptible
to damage, despite the presence of oxidant defense mech-
anisms that have evolved to eliminate free radicals and
restore redox homeostasis (Davies, 2001). Oxidative stress
has been implicated extensively in various physiological and
pathological processes, including aging (Stadtman, 1992),
cataract formation (Spector, 1995), neurodegenerative dis-
eases (Multhaup et al., 1997; Browne et al., 1999; Jenner,
2003; Uttara et al., 2009), cardiovascular diseases (Heistad
et al., 2009), diabetes (Baynes and Thorpe, 1999), pul-
monary diseases (Walters et al., 2008), osteoporosis
(Almeida et al., 2011), chronic inflammation (Weizman and
Gordon, 1990), and cancer (Brown and Bicknell, 2001;
Kumar et al., 2008).
Proteins are structurally more vulnerable to oxidative dam-
age than other biomolecules due, in part, to the relatively high
rate constant for their reactions with most free radicals in
stressed cells (Stadtman, 1993). Oxidative modification of
proteins causes a conformational change and structural
unfolding, leading to a loss of protein function (Davies and
Delsignore, 1987; Soto, 2003). However, proteins damaged by
environmental mechanisms or intracellular free radicals
(e.g. ROS) can be fragmented, undergo abnormal cross-link-
ing, and form toxic aggregates with other damaged proteins or
with normal cellular proteins (Tyedmers et al., 2010). Such
events are now known to cause various neurodegenerative
disorders and certain other systemic diseases (Dobson, 1999).
In cells whose redox tone is at homeostatic levels, chaper-
ones (e.g. Hsp27, Hsp70, and Hsp90) supervise the folding of
nascent proteins being produced in the endoplasmic reticulum
(ER) and help detect misfolded proteins via ER stress sensor
mechanisms (Hetz, 2012). These misfolded proteins are
ubiquinated, whereby ubiquitin molecules are covalently
attached via an E3 ubiquitin protein ligase called carboxyl ter-
minus of Hsp70-interacting protein (CHIP), and the ubiquiti-
nated proteins are targeted to and degraded by the ubiquitin/
proteasome system (UPS) (Park et al., 2007). In addition, late
molecular events for the disposal of short-lived and oxidized
proteins have been shown to include the 26S (via an ubiquitin
andATP-dependentmanner) or the 20Sproteasome-mediated
protein degradation in the cytosol and nucleus of eukaryotic
cells (HershkoandCiechanover, 1998;Vogeset al., 1999; Jung
and Grune, 2008; Dunlop et al., 2009). Alternatively, others
haveshown that oxidizedproteinsarecoupledwithchaperones
and incompletely degraded in cellular lysosomes, resulting in
autophagy which is associated with the formation of polymer-
ized, nontoxic lipofuscin-like deposits in tissues (Kiffin et al.,
2004; Kaushik and Cuervo, 2012). Thus, the mechanisms of
intracellular protein quality controls (for the degradation of
misfolded and senescent proteins) and protein oxidative dam-
age control (for the degradation of oxidant-damaged proteins)
overlap to some extent, and both include the relatively late
involvement of proteasomes. However, key questions remain
regarding the early molecular events in the detection of oxida-
tively damaged proteins. Firstly, is there a mechanism in cells
discerning oxidatively damaged proteins? Secondly, how does
the mechanism target oxidized proteins to the proteolytic
machinery for their degradation?
Here, we identified a novel proteinmodificationmechanism
that may answer the above questions. DSS1, a small, highly
acidic and eukaryotically conserved protein, plays a key role in
this mechanism. The deleted in split hand/split foot 1 (DSS1)
gene, located on chromosome 7q21.3–q22.1, was originally
identified as it is missing in patients with a dominant inherited
heterogeneous limb developmental disorder called ectro-
dactyly or split hand/split foot malformation type 1 (SHFM1)
(Crackower et al., 1996). Its encoded protein DSS1 or its
orthologs (e.g. Sem1 in Baker’s yeast) is now known to be
involved in many important biological and cellular processes
(Pick et al., 2009), such as genome stability (Marston et al.,
1999; Kojic et al., 2003; Gudmundsdottir et al., 2004; Li et al.,
2006), homologous recombination and DNA repair (Yang
et al., 2002; Kojic et al., 2005; Krogan et al., 2004; Zhou et al.,
2007; Liu et al., 2010), cellular proliferation and neoplastic
transformation (Wei et al., 2003), protein degradation (Fu-
nakoshi et al., 2004; Sone et al., 2004; Wei et al., 2008), his-
tone modification (Qin et al., 2009), and mRNA splicing,
metabolism, and export (Baillat et al., 2005; Thakurta et al.,
2005; Wilmes et al., 2008; Ellisdon et al., 2012). In present
study,wedescribe anovel role ofDSS1protein asamodifier in
a novel type of protein modification targeted to proteins
induced by oxidative stress in vitro and in cells. DSS1 forms
SDS-resistant adducts with these proteins, and the formation
can be promoted by Fenton’s reagent (generate hydroxyl free
radical) in vitro and in cells subjected to UV stress, and can
also be suppressed by free radical scavengers, such as DTT,
NAC, Vitamin C, α-lipoid acid. These results are implying that
the targeted proteins by DSS1 are products of oxidation,
namely oxidized proteins. The formation of DSS1-protein
adducts can also be enhanced by ATP supplementation,
suggesting that this novel role of DSS1 protein as a modifier
tagging target proteins is processed by an unidentified ATP-
ase. Furthermore, the proteins tagged with DSS1 are able to
be further ubiquitinated, which may enable their degradation
via theUPS-mediated proteolyticmechanism. Taken together,
a novel protein modification mechanism existing in cell is
revealed, which may discern oxidized proteins, modify them
with DSS1, and lead them to degradation.
RESULTS
DSS1 forms SDS-resistant adducts with cellular
proteins in vitro which are protected by Bortezomib,
a specific proteasome inhibitor
To determine whether DSS1 could form adducts with pro-
teins, we incubated HeLa lysates with equal amounts of the
biotin-labeled recombinant DSS1-V5-His protein (DSS1-
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biotin) (Fig. 1A) in the absence or presence of the protea-
some inhibitor, Bortezomib. After incubation, the HeLa
lysates treated and untreated with Bortezomib, along with
pure DSS1-biotin and HeLa lysate alone as controls, were
analyzed by Western blotting using streptavidin-horseradish
peroxidase (HRP) conjugate. As shown in Fig. 1B, prominent
protein bands representing DSS1-biotin and its oligomers
were detected at approximately the multiples of 20-kDa. In
addition, multiple high molecular weight protein bands
whose molecular weights were distinct from DSS1 and its
oligomers were more prominent when DSS1-biotin was
incubated with HeLa lysates (L3) than with DSS1-biotin
alone (L1) or HeLa lysate alone (L2). Importantly, the
amounts of these high-molecular-weight proteins exhibited
by biotin signal were significantly increased in the presence
of Bortezomib, suggesting that Bortezomib prevents their
degradation due to its known proteasome inhibitory activity
(Fig. 1B; L4). In order to ensure that the biotin label on the
initial DSS1 probe did not itself cause the formation of the
protein bands, we repeated the above experiments using an
in vitro [35S]-radiolabeled DSS1-myc fusion protein,
employing autoradiography to detect the labeled bands. Like
HeLa lysate/Bortezomib/DSS1-biotin mixtures, Fig. 1C (L5)
shows that HeLa lysate containing [35S]-labeled DSS1-myc/
Bortezomib mixtures produced multiple DSS1-associated
protein bands which were SDS-resistant. If these bands
were DSS1 oligomers formed by DSS1 itself, the observed






Figure 1. DSS1 forms SDS-resistant adducts with proteins in vitro with protection of Bortezomib. (A) After purification, the
purified and/or biotin-labeled DSS1-V5-His recombinant proteins were subjected to SDS-PAGE, and analyzed by Coomassie brilliant
blue (CBB) staining solution R250 or detected with WB using strepavidin-HRP or specific antibodies, including anti-DSS1s3259-2,
anti-DSS1FL70, anti-V5, and anti-His. (B) After overnight incubation of DSS1-biotin (20 ng) with HeLa lysate (50 μg) at 4°C in the
absence or presence of Bortezomib (20 μmol/L), the lysates were separated by SDS-PAGE and detected with streptavidin-HRP. The
membrane was stripped and re-probed with an anti-actin antibody and used as a loading control. (C) The 1 μg of myc-tagged empty
vector or vector with DSS1-myc was radiolabeled with L-[35S]-methionine (10 μCi) in an in vitro TNT cell-free protein synthesis
system, and incubated overnight at 4°C with HeLa lysate in the absence or presence of Bortezomib (20 μmol/L). The lysates were
prepared for IP using EZview Red anti-myc affinity resins (40 μL), followed by SDS-PAGE separation, and then the DSS1-containing
bands were identified by autoradiography.
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of the molecular weight of DSS1, however their molecular
weights were not equal to those of oligomerized DSS1. We,
therefore, conclude that DSS1 forms strong, SDS-resistant
associations with other proteins.
ATP promotes formation of DSS1 adducts with cellular
proteins
Since attachment of several protein modifiers, such as
ubiquitin and ubiquitin-like proteins, to their target proteins is
an ATP-dependent enzymatic process (Hershko et al., 1980;
van der Veen and Ploegh, 2012). We wondered whether
DSS1 attachment to its targets is a random reaction or an
enzymatic process. We first tested whether formation of
DSS1-protein adducts could be regulated by ATP. To do so,
the DSS1-biotin was incubated with HeLa lysates in the
presence of ATP. These experiments were performed in the
presence of irreversible inhibitor of cysteine peptidases, N-
ethylmaleimide (NEM), to block the functions of ubiquitina-
tion and de-ubiquitination. Our results show that the levels of
DSS1 adduct formation were significantly increased when
the HeLa lysate/DSS1-biotin mixtures were supplemented
with ATP (Fig. 2A; L5). In addition, the formation of DSS1
adducts was markedly increased in an ATP dose-dependent
manner, when the NEM-pretreated HeLa lysates were
digested beforehand with the ubiquitin specific protease 2
(USP2) to remove the pre-existing ubiquitin from its sub-
strates (Fig. 2B; L3 to L5). This observation is noteworthy
that, unlike ubiquitin and ubiquitin-like proteins, the formation
of DSS1-protein adducts is not sensitive to NEM, indicating
that the reaction of DSS1 tagging its target proteins does not
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Figure 2. ATP promotes the formation of DSS1 adducts with cellular proteins. (A) After overnight incubation of DSS1-biotin
(20 ng) with NEM-treated HeLa lysate (50 μg) at 4°C under the conditions indicated, the lysates were separated by SDS-PAGE and
detected using streptavidin-HRP or WB with anti-ubiquitin or anti-actin antibody. The pentagram star represents that the HeLa lysate
at L7 was denatured at 95°C for 10 min. ATP, 2 mmol/L; EDTA, 10 mmol/L; Bortezomib, 20 μmol/L; NEM, 25 mmol/L. (B) The manner
of DSS1 adduct formation is ATP dose-dependent. The NEM-treated HeLa lysates were digested with the USP2 (1 μg) to remove the
pre-existing ubiquitin from its substrates. Actin served as an equal loading control.
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metal ion chelator frequently recruited to inhibit ATPase
activity by chelating Mg2+ or Ca2+, effectively inhibited the
DSS1 adduct formation (Fig. 2A and 2B; L6). Moreover,
denatured HeLa lysate (marked with a pentagram star) did
not exhibit an ability of forming DSS1-protein adducts in a
working condition (Fig. 2A; L7). These findings strongly
suggest that formation of DSS1-protein adducts is pro-
cessed by an unidentified ATPase, whose catalytic mecha-
nism is distinct from that of E1, E2, and E3 pathways
performing ubiquitination (Hershko et al., 1980) and ubiqui-
tin-like protein modifications (van der Veen and Ploegh,
2012).
Free radicals increase number and protein levels
of DSS1 targets
To determine what proteins are DSS1 targets, we tested
multiple conditions that may regulate the formation of the
tight interactions between DSS1 and its target proteins.
Unexpectedly, we found that dithiothreitol (DTT) was able to
reduce these interactions (Fig. S1), suggesting that DSS1
and its targets associated via the linkages of disulfide bonds.
However, there is no cysteine residue in the amino acid
sequence of DSS1 or in the fusion tags (e.g., V5, Myc, DDK,
and HTBH) used in our experiments. Since DTT is known as
an antioxidant and is able to eliminate oxidative species,
such as ROS, we speculated that the observed effect of DTT
was due to its elimination of oxidative species and that
addition of oxidants may increase the number and level of
DSS1 targets. Our data show that there was no significant
increase in the levels of DSS1-protein adducts in H2O2-
treated HeLa lysates (data not shown). However, when the
Fenton’s reagent (a mixture of H2O2 and Fe
2+ that can
immediately generates hydroxyl free radicals OH·) (Fenton,
1894) was added to the HeLa lysate, more DSS1-protein
adducts were detected compared with reactions lacking
H2O2 and Fe
2+ (Fig. 3; L4 and L5). This enhance of DSS1-
protein adducts in the presence of H2O2 and Fe
2+ was fur-
ther augmented by the presence of ATP (Fig. 3; L5 and L7).
These results suggest that free radicals, at least hydroxyl
free radicals, can directly promote the increase in the num-
ber and protein levels of DSS1 targets. Since the immediate
consequence of free radicals generated in cell lysates is
oxidizing cellular components, including proteins, we spec-
ulate that DSS1 targets are proteins attacked by free radi-
cals. Further more direct experimental evidence is required
to confirm this.
UV radiation causes DSS1 adduct formation in cultured
cells
As UV radiation is well established as an effective means of
generating ROS, in particular producing the highly reactive
hydroxyl radicals OH·, in cultured cells (Masaki et al., 1995),
we therefore sought to determine whether UV radiation, like
chemical-induced oxidative stress, enhances the formation
of DSS1 adducts in cells. To this end, we generated the
stable clones using HEK293F and HeLa cell lines that were
infected with retroviral vector expressing a physiological
level of the HTBH-tagged DSS1 recombinant protein. The
HTBH tag used contained two His×6 tags (H) that flank a
protease cleavage site (T) of tobacco etch virus (TEV) and a
signal peptide for endogenous biotinylation (B), making it
possible to obtain highly pure protein using affinity purifica-
tion of multiple steps. Upon treatment of these stable clones
with UVB radiation, the whole-cell lysates were affinity puri-
fied using Ni2+-NTA columns and analyzed for DSS1-protein
adducts using streptavidin-HRP (Fig. S2). Cells were har-
vested six hours later after treatment. UVB radiation led to an
increase in the levels of HTBH-tagged DSS1-protein adducts
in a dose-dependent manner (Figs. 4A and S3). In fact, at
6 h post-exposure to UVB radiation resulted in maximal
amounts of the HTBH-tagged DSS1-protein adducts, few or
no adducts remained when cells were harvested after 9–12 h
(Fig. 4B), suggesting that the DSS1-protein adducts are UVB
stress-inducible and are to be degraded over time.
Taking the advantage of having these stable cell clones
expressing DSS1-HTBH or HTBH alone and the methods
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Figure 3. Fenton-induced free radicals increase the number
and protein level of DSS1 targets in vitro. Fenton-mediated
oxidative stress was conducted by incubation of H2O2 and
FeSO4 (100 μmol/L each) with NEM (25 mmol/L)-treated HeLa
lysate (50 μg) for 3 h at 30°C to generate the highly reactive
hydroxyl radical for oxidative damage to proteins. The DSS1-
biotin (20 ng) was then incubated with the oxidant-damaged
HeLa lysates (50 μg) overnight at 4°C when subjected to the
conditions indicated. Actin was present as a loading control.
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we next tested whether free radical scavengers, such as
N-acetylcysteine (NAC), Vitamin C (Vit C), α-lipoic acid (αLA)
suppress the formation of DSS1-protein adducts. As expected,
all of themworkedeffectively ina dose-dependentmanner (Fig.
S4). Theaffection of these antioxidants is consistentwith that of
DTT previously used in vitro, confirming that free radicals are
the direct factors producing target proteins of DSS1.
To further demonstrate that HTBH-tagged DSS1 forms
conjugates with cellular proteins in response to UVB injury, we
pulled down the Ni2+-affinity-purified proteins from the UVB-
treated DSS1-HTBH-expressing HEK293F cells using strep-
tavidin-agarose beads, followed by washing them with SDS
buffer to denature and dissociate the binding partners (e.g.,
proteasome subunits) from the HTBH-tagged DSS1 protein
complexes (Wei et al., 2008), thus preserving only DSS1 and
SDS-resistant DSS1-protein adducts (Fig. S5). The DSS1-
HTBH fusion protein was then cleaved in-gel at the TEV
cleavage site of the HTBH tag, thereby removing the HTBH tag
and allowing the release of DSS1 and DSS1-protein adducts
from agarose beads. The DSS1 and themultiple DSS1-protein
adducts were detected in the doubly (two-step) affinity-purified
lysates from the UVB radiation-exposed HEK293F stable cell
lines expressing DSS1-HTBH using CBB-R250 protein stain-
ing solution (Fig. 4C) and an anti-DSS1 antibody (Fig. 4D; left
panel). As expected, neither the DSS1 nor the DSS1-protein
conjugates were detected in the doubly affinity-purified lysates
of UVB-treated cells with streptavidin-HRP after removal of the
biotinylated signal sequence (Fig. 4D; right panel).
To identify the potential DSS1-protein adducts induced by
UVB radiation, the individual polypeptide bands, as indicated
by arrows in Fig. 4C, were excised and performed with tryp-
sinolysis and then identifiedby liquid chromatography coupled
with tandem MS (LC-MS/MS). Only the proteins represented
by at least two peptide counts and 5% amino acid coverage
were considered as valid hits.We identified 39 highly potential
proteins that were exclusively present in samples from the
UVB radiation-exposed HEK293F/DSS1-HTBH-C14 cells
and that are absent in untreated cells (Table 1). These
potential candidates of the UVB radiation-induced DSS1-
protein adducts are involved in many important biological
events and pathways, including (1) post-translational modifi-
cation, protein turnover, and chaperones; (2) translation initi-
ation and elongation; (3) ribosome biogenesis; (4)
transcriptional regulation; (5) post-transcriptional RNA pro-
cessing, metabolism, and export; (6) DNA replication,
recombination, and repair; (7) cytoskeleton assembly; and (8)
oxidation-reduction (redox) processes. RPN3, RPN6, and
PCID2 (PCI domain containing protein 2) were randomly
chosen among the identified DSS1 targets for a further veri-
fication by Western blotting, to see if they are modified with
DSS1 protein after cells exposure to oxidative stress induced
by UVB radiation (Fig. 4E). Each of them is individually rep-
resented by their own antibody at an increased level that is
about equal to the original size plus DSS1. This result also
shows that the sample, extracted from UVB-treated cells, has
much more DSS1-protein adducts than that from non-UVB-
treated cells, which is consistent with the former results
(Fig. 4C and 4D). Therefore, our data exclude the possibility
that DSS1-protein adducts are oligomers formed by DSS1
itself. These results also clearly demonstrate that the attach-
ment of DSS1 to other cellular proteins occurs in response to
UVB-mediated oxidative stress.
Four evolutionarily conserved DSS1 amino acid
residues are critical for the UV radiation-induced
formation of DSS1-protein adducts
Given that DSS1 is evolutionarily conserved in eukaryotic
species, we next sought to determine whether its ability to
Figure 4. UV radiation promotes the formation of DSS1-
protein adducts in cultured cells. (A) The formation of DSS1-
protein adducts was enhanced by UV radiation in a dose-
dependent manner using different stable clones. HEK293F cells
stably expressing HTBH alone (named HTBH-mix, -C14, and
-C18) or DSS1-HTBH (designated as DSS1-HTBH-mix, -C2,
-C9, -C14, and -C19) were irradiated with or without UVB at
doses ranging from 80 to 160 mJ/cm2. Six hours after exposure,
the lysates (500 μg) were prepared for pull-down assay with Ni-
NTA beads (40 μL), and DSS1 and its conjugates were
identified by streptavidin-HRP. (B) DSS1-protein adducts
formed in a time-dependent manner. Following exposure to
UVB radiation, the HEK293F/DSS1-HTBH-C2 cells were har-
vested at a series of time points as indicated. The lysates
(500 μg) were purified by Ni-NTA beads (40 μL), and then DSS1
and its protein adducts were detected with streptavidin-HRP.
(C) DSS1-protein adducts were detected with CBB staining
solution. DSS1 and its protein adducts extracted from the
untreated or UVB-treated HEK293F/DSS1-HTBH-C14 cell
lysates (100 mg) were pulled down by Ni2+-NTA (1 mL) and
streptavidin-agarose beads (1 mL), cleaved with AcTEV prote-
ase, and then identified by staining with CBB-R250 solution.
The potential candidates of DSS1-protein adducts were indi-
cated by arrows. (D) DSS1 was specifically recognized in
DSS1-protein adducts. The doubly affinity-purified proteins from
HEK293F/HTBH-C14 or HEK293F/DSS1-HTBH-C19 cell
lysates were subjected to SDS-PAGE and then analyzed by
streptavidin-HRP or WB with an anti-DSS1FL70 antibody.
(E) Three potential candidates of UVB-mediated DSS1-protein
adducts were verified using the pull-down and WB assays. The
Ni2+-affinity-purified proteins isolated either from the untreated
or UVB (160 mJ/cm2)-treated HEK293F/HTBH-C18 or
HEK293F/DSS1-HTBH-C14 cells were further pulled down by
streptavidin-agarose beads, washed with ATP wash buffer (4×),
and then cleaved in-gel by AcTEV protease to remove the
HTBH tag. The DSS1 recombinant protein as well as the
multiple DSS1-protein adducts were concentrated and ana-
lyzed by WB with indicated antibodies, including anti-RPN3,
anti-RPN6, anti-PCID2, and anti-DSS1FL70. The membrane
was stripped and re-probed with an anti-DSS1FL70 antibody
and used as a positive control for the pull-down assays.
s
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Table 1. Identification of the potential candidates of UVB-induced DSS1-protein adducts by mass spectrometry
Protein namea Accession #b Amino acid #c M.W. (Da)d Referencee WBf
I. Post-translational modification, protein turnover and chaperones
26S proteasome non-ATPase regulatory subunit 11
(PSMD11/RPN6/S9)
NP_001257411 422 47,333 PCI yes
26S proteasome non-ATPase regulatory subunit 3
(PSMD3/RPN3/S3)
NP_002800 534 60,847 PCI yes
26S proteasome non-ATPase regulatory subunit 6
(PSMD6/RPN7/S10a)
NP_055629 389 45,400 PCI yes
E3 SUMO-protein ligase PIAS1 NP_057250 651 71,705
E3 ubiquitin-protein ligase tripartite motif-containing
protein 33 (TRIM33) isoform α
NP_056990 1,127 122,403
E3 ubiquitin-protein ligase tripartite motif-containing
protein 33 (TRIM33) isoform β
NP_148980 1,110 120,410
Heat shock cognate 71 kDa protein (HSP71)
isoform 1
NP_006588 646 70,767
Heat shock cognate 71 kDa protein (HSP71)
isoform 2
NP_694881 493 53,387
II. Translation initiation and elongation
Eukaryotic translation initiation factor 3 subunit A
(eIF3A)
NP_003741 1,382 166,439 PAM
Eukaryotic translation initiation factor 3 subunit C
(eIF3C)
NP_003743 913 105,213 PAM yes
Eukaryotic elongation factor 1α1 (eEF1A1) NP_001393 462 50,010
Eukaryotic elongation factor 1α2 (eEF1A2) NP_001949 463 50,339
Eukaryotic elongation factor 1γ (eEF1C) NP_001395 437 49,988
Eukaryotic elongation factor 2 (eEF2) NP_001952 858 95,207
III. Ribosome biogenesis
ATP-dependent RNA helicase DDX42 (RHELP) NP_031398 938 102,844
Midasin NP_055426 5,596 632,692
Ribosome production factor 2 (RPF2) homolog NP_115570 306 35,452
IV. Transcriptional regulation
Transcription initiation factor TFIID subunit 2 NP_003175 1,199 136,855
Transcriptional repressor protein YY1 NP_003394 414 44,582
DNA topoisomerase 1 NP_003277 765 90,595
Paired amphipathic helix (PAH) protein SIN3a NP_001138829 1,273 145,045
Staphylococcal nuclease domain-containing protein
1 (SND1)
NP_055205 910 101,866
V. Post-transcriptional RNA processing, metabolism and export
Heterogeneous nuclear ribonucleoprotein U isoform
α (hnRNP Uα)
NP_114032 825 90,454
Heterogeneous nuclear ribonucleoprotein U isoform
β (hnRNP Uβ)
NP_004492 806 88,849
Putative RNA-binding protein 15B (RBM15B/OTT3) NP_037418 890 97,075
RNA-binding protein 33 (RBM33) NP_444271 1,170 129,855
Ataxin-2 (ATX2) NP_002964 1,313 140,152
Serine/threonine-protein kinase pre-mRNA-
processing factor 4 (PRP4) homolog
NP_003904 1,007 116,856
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form adducts with these proteins is an evolutionary-con-
served function found in other eukaryotes. To address this,
we fused the HTBH-DDK (DDK is the same with FLAG) tag
DNA sequence to the 3′ end of human DSS1 cDNA, des-
ignated as HsDSS1-HTBH-DDK, and used this construct to
subclone DSS1 orthologous genes respectively from eight
different species ranging from yeast to mice and humans,
including S. cerevisiae (Baker’s yeast), C. elegans (Round-
worm), A. thaliana (Flowering plant), D. melanogaster (Fruit
fly), D. rerio (Zebrafish), X. laevis (Frog), X. tropicalis (Frog),
M. musculus (Mouse), and R. norvegicus (Rat). These
orthologs were transiently transfected into HEK293F cells
respectively. The host cells were treated with UVB and
harvested at 6 h post-exposure to UVB radiation. The for-
mations of DSS1-ortholog adducts in these host cells were
examined with streptavidin-HRP on Western blotting after a
Ni2+ affinity purification. All DSS1 orthologs recruited in this
study presented their capabilities of forming adducts with
other proteins in their host cells subjected to UVB radiation
(Fig. 5A). Based on this result, we speculate that the key
amino acid(s) involved in connecting DSS1 to its targets
must be conserved in these DSS1 orthologs. Sequence
alignment of human DSS1 protein with its orthologs identi-
fied 15 amino acid residues located in human DSS1 protein
that are highly evolutionarily conserved (Fig. 5B). To identify
residues critical for UVB-induced formation of DSS1-protein
adducts, we substituted all 15 of these highly conserved
amino acids in human DSS1 protein one by one using base
substitutions or point mutations. A significant decrease
(∼50%–70%) in the capacity of DSS1 to associate with cel-
lular proteins, compared with wild-type DSS1, was observed
when the aromatic amino acid residue W27, W39, W43, or
F52 was changed into Gly (G) or Ala (A) (Fig. 5C). In con-
trast, there was no significant change in UVB radiation-
induced formation of DSS1-protein adducts among other
DSS1 mutants examined (Figs. 5C and S5). These mutants
in DSS1 protein include L10A, L12A, L13A, F22L, E25G,
L30A, D31R, E32G, E34G, D35R, H37I, E40G, D44G,
D45G, D46G, D51G, L56I, L60I, Y65L, and G64AY65L. In
addition, the formation of DSS1-protein adducts was nearly
abolished when three or four of Trp (W) and/or Phe (F) were
substituted with Gly (G) and/or Ala (A) at 27, 39, 43, or 52,
Table 1. continued
Protein namea Accession #b Amino acid #c M.W. (Da)d Referencee WBf
WD repeat-containing protein 63 (WDR63) NP_660155 891 102,804
Prelamin-A/C isoform 3 NP_001033707 397 44,550
PCI domain-containing protein 2 (THP1/PCID2
or CSN12-like)
NP_001120674 399 45,899 PCI yes
VI. DNA replication, recombination and repair
Flap endonuclease 1 (FEN1 or RAD2) NP_004102 380 42,462
VII. Cytoskeleton assembly
Coiled-coil domain-containing protein 39
(CCDC39)
NP_852091 941 109,770
Cytoskeleton-associated protein 5 (CKAP5)
isoform α
NP_001008938 2,032 225,365
Cytoskeleton-associated protein 5 (CKAP5)
isoform β
NP_055571 1,972 218,395
Dynein heavy chain 6, axonemal NP_001361 4,158 475,854
Talin-2 NP_055874 2,542 271,483
VIII. Redox processes
Thioredoxin reductase 1 (TRXR1), cytoplasmic
isoform 1
NP_003321 551 60,288
Thioredoxin reductase 1 (TRXR1), cytoplasmic
isoform 3
NP_001087240 649 70,775
a The proteins represented by at least two peptide counts and 5% amino acid coverage were considered only as valid hits and determined by
protein score confidence index (C.I.).
b Accession numbers of the identified proteins were analyzed and indicated using SEQUEST against NCBI human protein database.
c The numbers of amino acids from the potential protein candidates were indicated.
d The molecular weight (dalton) of the identified proteins was calculated using the protein sequence relativizer.
e PCI domain: proteasome, COP9 signalosome and eIF3; PAM domain: PCI associated module.
f The potential candidates with PCI or PAM domain were confirmed for the formation of UVB radiation-induced DSS1-protein adducts by WB
using the specific antibodies.
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Figure 5. Four evolutionarily conserved DSS1 amino acid residues are critical for the formation of DSS1-protein adducts.
(A) Formation of the DSS1-protein adducts is highly conserved through evolution. The 4 μg of HTBH-DDK-tagged human DSS1 or its
orthologous genes cloned from eight different species was transiently transfected into the HEK293F cells for 42 h using
lipofectAMINE® and PLUSTM reagents. Six hours after exposure to UVB radiation at 160 mJ/cm2, the lysates (500 μg) were prepared
for IP with EZviewTM Red anti-FLAG® M2 affinity gel beads followed by detection with streptavidin-HRP. (B) Multiple sequence
alignments for the DSS1 protein family from various species. Amino acid sequences were retrieved from Uniprot database (http://
www.uniprot.org/) in FASTA format, and loaded into the Jalview program (Waterhouse et al., 2009). Protein alignments were gen-
erated using the Clustal X web services with default parameters through Jalview, and colored with Clustal X color scheme. Degree of
amino acid conservation was indicated by the height and color of the “Conservation” bars. The details about the conservation, quality,
and consensus calculations of DSS1 protein alignments can be found in website (http://www.jalview.org/help.html). “ - ” was intro-
duced to optimize sequence alignments. Human: HsDSS1 (Q13437); Mouse: MmDss1 (Q13437); Rat: RnDss1 (D3ZHW9); Zeb-
rafish: DrDss1 (Q7ZU84); Frog: XlDss1 (Q66KW8) and XtDss1 (Q28EZ1); Fruit fly: DmDss1 (Q9VM46); Mouse ear cress: AtDss1
(Q9XIR8); Baker’s yeast: ScSem1 (O94742); Nematode: CeDss1 (Q95Y72). (C) Identification of the amino acid residues crucial for
the formation of UVB-induced DSS1-protein adducts. The site-directed mutagenesis was performed using human DSS1 gene to
substitute the highly conserved amino acid residues. The wild-type DSS1 or its mutant genes, fused with the HTBH-DDK nucleotide
sequences at their 3′-ends, were expressed separately in HEK293F cells. The UVB-induced DSS1-protein adduct formation was
compared between wild-type DSS1 and its mutants. (D) Overexpression of the human DSS1 gene with substitution mutations at
positions W27, W39, W43, and F52 in HEK293F cells completely abrogated the UVB-induced DSS1-protein adduct formation.
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suggesting that they are indispensable for UVB radiation-
induced formation of the DSS1-protein adducts (Fig. 5D).
These results were further confirmed in UVB-irradiated
HEK293F/DSS1W27GW39GW43GF52A-HTBH stable clones
when compared with HEK293F/DSS1-HTBH clones (Fig.
S7). Taken together, Trp (W) at 27, 39, 43 and Phe (F) at 52
are critical residues for the formation of DSS1-protein
adducts. Since these four residues are conserved in all
eukaryotic species whose DSS1 gene have been
sequenced, it is probable that the formation of DSS1-protein
adducts in cells under oxidative stress is an evolutionarily
conserved mechanism in eukaryotic species.
Subsequent ubiquitination after DSS1-protein adducts
formation
As noted above, the formation of DSS1-protein adducts,
induced either by chemical or UVB-mediated oxidative
stress, is increased in the presence of proteasome inhibitor,
Bortezomib, implying that DSS1-protein adducts can be
degraded by the proteasome. We therefore investigated
whether DSS1-protein adducts are tagged with ubiquitin
after their formation by incubating DSS1-biotin with NEM-
treated or untreated HeLa lysates in the presence of ATP
and Bortezomib, as well as increasing concentrations of
Fenton’s reagent. The incubated lysates were analyzed
using streptavidin-HRP to recognize DSS1-biotin and DSS1-
protein adducts. As expected, Fenton’s reagent led to an
increase in DSS1-protein adducts in a dose-dependent
manner (Fig. 6; left top panel). A dramatic increase in the
level of high molecular weight DSS1-associated proteins
greater than 250 kDa was observed in NEM-deficient lysates
(Fig. 6; right top panel), whereas most DSS1-protein adducts
detected in lysates with NEM were smaller than 250 kDa
(Fig. 6; left top panel). Furthermore, when these lysates were
probed with an anti-ubiquitin antibody, ubiquitin-conjugated
proteins were also of a higher molecular weight when com-
pared with lysates treated with NEM (Fig. 6; middle panels).
The data suggest that ROS-induced DSS1-protein adducts
were further conjugated by poly-ubiquitin in the absence of
NEM. It is worthy to notice that it is the following ubiquiti-
nation must be performed on the target proteins of DSS1,
rather than DSS1 itself, since the lysine residues within
DSS1 were irreversibly cross-linked with biotin. The poly-
ubiquitination of DSS1-protein adducts after their formation
implies that these ubiquinated DSS1-protein adducts
undergo subsequent degradation mediated by the ubiquitin-
proteasome system.
DISCUSSION
The present study has revealed a cellular mechanism, in
which DSS1 protein, as a novel modifier, is attached to
numerous cellular proteins via an ATPase-mediated pro-
cess. Also, it shows that the DSS1-protein adducts can be
subsequently modified by ubiquitination, implying the
degradation of these target proteins via the ubiquitin-pro-
teasome system.
It has been observed that cellular proteins that are
strongly associated with the DSS1 molecule are resistant to
SDS treatment or denaturation. These associations could
either arise from the interaction of covalent or non-covalent
bonds. Previous studies have shown that a number of pro-
teins could form SDS-resistant complexes with cellular pro-
teins, including synaptic SNARE complex (Fasshauer et al.,
1998), phage tail spike endorhamnosidase (Goldenberg
et al., 1982), gp210 nuclear pore complex protein (Favreau
et al., 2001), prion-like protein (Speransky et al., 2001),
truncated mutant huntingtin exon 1 protein (Waelter et al.,
2001), and ubiquitin-like protein HUB1 (Lüders et al., 2003).
However, unlike the above protein complexes, the formation
of DSS1-protein adduct is significantly promoted by ATP, and
could be greatly suppressed by the metal ion chelator EDTA
and heat-induced denaturation. These results suggest that
formation of the DSS1-protein adducts is an enzymatic
process catalyzed by an as yet unidentified ATPase,
meaning DSS1 behaves more like ubiquitin and ubiquitin-like
protein (except for HUB1) than the above proteins, whose
conjugation to its target proteins is through a covalent link-
age. However, unlike ubiquitin or ubiquitin-like protein mod-
ifiers, DSS1 has four critical amino acid residues, three Trp
(W) and one Phe (F), involved in its attachment to the tar-
geted proteins, implying that this conjugation is carried out
by a particular mechanism (Fig. 5). For the convenience to
describe this novel type of protein modification in future
study, we name it as DSSylation.
It is worth considering whether the DSS1-protein adducts
observed are genuine mixed species or DSS1 oligomers
with unknown modifications. There are two kinds of protein
post-translational modifications that could render their tar-
gets with a significant molecular weight increase, including
glycation or glycosylation and ubiquitination or ubiquitin-like
protein modification. However, we can rule out these modi-
fications for the following reasons: firstly, our experimental
conditions did not allow glycosylation or glycation to occur,
because no sugar was supplemented in vitro; secondly, in
the experiments supplied with NEM, the formation of the
DSS1-protein adducts was not affected, whereas the ubiq-
uitination was inhibited irreversibly (Fig. 2). Theoretically,
ubiquitin and ubiquitin-like protein modification would be
inhibited due to the irreversible NEM-inactivation of E1, E2,
and DUBs-like enzymes. Most importantly, the proteomic
identification (Table 1) and WB verification with protein
specific antibodies (Fig. 4E) unambiguously demonstrated
the presence of many other proteins that form adducts with
DSS1.
Prior to the present study, the involvement of DSS1 pro-
tein in many critical cellular events and processes has been
illustrated, but its role as a modifier attached to the proteins
of interest in cells under oxidative stress has not previously
been demonstrated. We show here for the first time that
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DSS1 plays a novel role in tagging many proteins in cells
under conditions of oxidative stress. The formation of DSS1-
protein adducts is conditionally induced by free radicals,
which were generated, in this study, by Fenton’s reagent in
cell lysate or in cells subjected to UV-induced oxidative
stress, and also can be abolished by various free radical
scavengers. Since the direct consequence of proteins
encountered with free radicals is being oxidized, we logically
infer these target proteins of DSS1 are probably oxidized
proteins. This hypothesis remains to be supported by a direct
demonstration. Through its attachment to these proteins,
DSS1 may play a role as a common trait of the target pro-
teins leading to the recognition of certain E3 ligase thus
assists their subsequent ubiquitination and degradation via
the ubiquitin-proteasome system. The putative function of
DSSylation is summarized in Fig. 7.
Every living organism is frequently exposed to various
oxidative stressors generated in the outer environments and
inner pathological activities. Evolving a defense system
against oxidative stress is critical for all creatures on earth.
Scavenging mechanisms including various antioxidant
reagents and enzymes have been found in cells to eliminate
free radicals. However, level of free radicals often overcome
the defense of scavenging mechanisms in cells exposed to
environmental stressors or under certain pathophysiological
conditions, resulting in oxidative stress. Proteins, the major
cellular component, are naturally the major targets of free
radicals. Oxidatively damaged proteins are quite cytotoxic,
especially when they form aggregates. Accumulated protein
aggregates have been considered as major inducing factors
of multiple human diseases (Dobson, 1999). Thus, timely
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Figure 6. The DSS1-protein adducts are able to be subsequently ubiquitinated. Each reaction containing DSS1-biotin (20 ng)
and NEM (25 mmol/L) (A) or non-NEM-treated HeLa lysates (50 μg total protein) (B) was incubated with increasing doses (62.5–
500 μmol/L) of Fenton’s reagent in the presence of Bortezomib (20 μmol/L) and ATP (5 mmol/L). The reactions with free radicals
generated by Fenton’s reagent were incubated at 30°C for 3 h. After overnight incubation at 4°C, the lysates were separated by SDS-
PAGE and then followed by the detection with streptavidin-HRP or WB probed by anti-ubiquitin or anti-actin antibody. Actin served as
a control for equal loading of proteins.
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oxidative stress. We have shown that proteins targeted by
DSS1 are enhanced in the presence of free radicals gen-
erated by Fenton’s reagent in vitro and by UV radiation in
cultures, implying this novel mechanism introduced in this
study may play a role in cleaning oxidized proteins and
maintaining the viability of stressed cells. Previous studies
have demonstrated that loss of the Dss1 gene results in
acute sensitivity to injures caused by oxidative stressors,
such as chemicals, UV, and IR radiation (Kojic et al., 2003;
Funakoshi et al., 2004). Since DSS1 is highly conserved in
all eukaryotic species, we speculate that this mechanism is




NAC, Vit C, αLA, ATP, CBB-R250, EDTA, FeSO4, glycerol, H2O2,
imidazole, NaCl, NaH2PO4, NEM, Nonidet P40, PMSF, puromycin
solution, SDS, Tris-HCl, Triton X-100, EZviewTM Red affinity gels
(including streptavidin-HRP, anti-myc, and anti-FLAG® M2), anti-
actin (1:2000), and anti-FLAG M2 (1 μg/mL) antibodies were from
Sigma-Aldrich (St. Luis, MO); USP2, anti-RPN7 (1:1000), and anti-
ubiquitin (1:1000) antibodies from Enzo Life Sciences (Farmingdale,
NY); anti-RPN6 antibody (1:1000) from Novus Biologicals (Littleton,
CO); AcTEV protease, DTT, IPTG, MgCl2, lipofectAMINE
®, PLUSTM
reagent, and anti-V5 (1:5000) antibodies from Life Technologies
(Grand Island, NY); strepavidin-HRP conjugate (1:3000) from GE
Healthcare (Piscataway, NJ); Bortezomib from LC Laboratories
(Woburn, MA); anti-PCID2 (1:500) and anti-DSS1FL70 (1:500)
antibodies from Santa Cruz Biotechnology (Santa Cruz, CA); com-
plete EDTA-free protease inhibitor cocktail from Roche (Indianapolis,
IN); anti-eIF3C antibody (1:15,000) from Bethyl Laboratories
(Montgomery, TX); anti-His (1:500) antibody from EMD Biosciences
(San Diego, CA); anti-RPN3 and anti-DSS1s3259-2 (1 μg/mL)
antibodies from Proteintech (Chicago, IL); EcoRV, SgfI, and MluI
restriction enzymes are from New England Biolabs (Ipswich, MA).
DNA construction and mutagenesis
The full-length human DSS1 (HsDSS1) gene fused in frame with a
V5 epitope-tagged sequence at the 3′ end was amplified by poly-
merase chain reaction (PCR). Forward and reverse primers were
Figure 7. DSSylation acts as a proposed mechanism for tagging the degradation of the oxidant-damaged proteins. The
image was adapted from the website of the United States Department of Energy’s Genomics: http://doegenomestolife.org. In stressed
cells, DSSylation was promoted by free radicals (e.g., ROS) generated from environmental stressors such as UV light, X-rays, and
chemicals. In addition, the UVB radiation-induced DSSylation could be suppressed after treatment of the cells with potent antioxi-
dants, including NAC, αLA, and Vit C. Once oxidized proteins were conjugated with DSS1 molecule via an ATP-catalyzed enzymatic
system, the DSSylated protein substrates were presumably able to be tagged with ubiquitin by E1/E2/E3 modification pathways
followed by a recruitment of (Ub)n/DSS1 substrates into the 26S proteasome for degradation. Molecular dissection of the human
DSS1 protein sequence identified four residues at positions W27, W39, W43, and F52 are required for the UVB radiation-induced
DSSylation.
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5′-GGTACCA TGTCAGAGAAAAAGCAGCC-3′ and 5′-ACCGGTA
CGCGTAGAATCGAGA-3′, respectively. PCR was performed as
described previously (Wei et al., 2003). PCR-amplified DSS1-V5
DNA was cloned into pEXP5-CT/TOPO with a 6× His tag at its
COOH-terminus (Invitrogen). HsDSS1 and its mutant gene
(HsDSS1W27GW39GW43GF52A) were also inserted into the SgfI and
MluI cloning sites of retroviral vector pQCXIP (Clontech, Mountain
View, CA) with an HTBH tag at their COOH-terminals (Wang et al.,
2007) (a kind gift from Dr. Lan Huang, UC Irvine, CA) using the
LigaFast Rapid DNA Ligation System (Promega, Madison WI). The
HTBH and HsDSS1-HTBH DNA fragments were respectively sub-
cloned into pCMV6-entry-mycDDK plasmids (OriGene, Rockville,
MD) using the SgfI and EcoRV sites. Genes encoding DSS1 or
DSS1-like proteins were also cloned from eight different species,
including mouse (CD-1 skin tissue), rat (pCMV6-RnDss1-mycDDK;
OriGene), frog (pDNR-LIB-XlDss1 and pCS108-XtDss1; Open Bio-
systems, Lafayette, CO), zebrafish (ZF4 fibroblast; ATCC), fruit fly,
thale cress (Heynh. strain: S8-1-2A; ATCC), Baker’s yeast, and
nematode (N2 strain). All DSS1 genes were separately subcloned
into pCMV6-HsDSS1-HTBH-DDK between SgfI and MluI to replace
HsDSS1. Deletion and point substitution mutant clones were gen-
erated using a QuikChange Site-Directed Mutagenesis Kit (Agilent,
Clara, CA). All DNA sequences were verified by the DNA Core
Facility (UT Health Science Center at San Antonio, San Antonio, TX)
using an ABI 7700 Sequence Detection System (Applied Biosys-
tems, Foster City, CA).
Purification of human DSS1 recombinant protein
The E. coli strain BL21 (DE3) was transformed with the pEXP5-CT/
DSS1-V5-His plasmid encoding a human wild-type DSS1 with a V5-
His tag at its COOH-terminus by a heat-shock method. The
expression of DSS1-V5-His recombinant protein was induced by
adding 1 mmol/L of IPTG for 3 h at 37°C with a vigorous shaking till
the cell density reading at OD600 = 0.5–0.6. The bacterial cells were
harvested by spinning at 4,000 g for 20 min at 4°C and re-sus-
pended in 200 mL lysis buffer [50 mmol/L Tris-HCl (pH = 8.0), and
1 mmol/L PMSF]. After incubation for 30 min at 25°C room tem-
perature, the cells were processed by sonication with Bioruptor
(pulse 5 s on and 23 s off; total 10 min) (diagenode, Sparta, NJ) to
lyse cells and shear DNA completely. The crude extract was cen-
trifuged at 50,000 g for 20 min at 4°C and then flew through a 2 mL
Ni-NTA nickel column (Novagen), which was pre-equilibrated with
20 mmol/L Tris-HCl (pH = 8.0), 150 mmol/L NaCl, 0.1% Triton X-100,
and 40 mmol/L imidazole. After applying the sample, the column was
washed with 40 mL wash buffer [20 mmol/L Tris-HCl (pH = 8.0),
500 mmol/L NaCl, and 40 mmol/L imidazole]. The DSS1-V5-His
recombinant protein was eluted with 1× TBS [20 mmol/L Tris-HCl
(pH = 7.4) and 0.9% NaCl] containing 50 mmol/L EDTA followed by
loading it onto the 1 mL HiTrap Capto DEAE ion exchange column
(GE Healthcare). The bound DSS1-V5-His protein was eluted by a
linear salt gradient from 150 mmol/L to 1 mol/L NaCl. The pooled
fractions containing DSS1 protein were collected and the NaCl salt
concentration was adjusted to 2 mol/L. The DSS1-V5-His protein
was further purified after loading onto a 1 mL HiTrap phenyl HP
column (GE Healthcare). The purified DSS1-V5-His was subjected
to the Superdex 75 10/300 GL size exclusion chromatography (GE
Healthcare) to exchange the buffer system from Tris-HCl to 1× PBS
(pH = 7.4) (137 mmol/L NaCl, 2.68 mmol/L KCl, 10.1 mmol/L
Na2HPO4, and 1.76 mmol/L KH2PO4). The purified DSS1-V5-His
fusion protein was collected and concentrated to 5 mg/mL. The
DSS1-V5-His fusion protein was subjected to 4%–12% Bis-Tris
SDS-PAGE gels (Life Technologies), verified by protein staining with
CBB-R250 solution.
DSS1 protein biotinylation
A one-step procedure for DSS1 protein biotinylation was performed
by EZ-Link NHS-PEG4 kit (Pierce, Rockford, IL). The N-hydroxy-
succinimide ester (NHS) group reacts specifically and efficiently with
the side chain of Lys (K) residues and the NH2-terminal amino group
of DSS1-V5-His fusion protein to form irreversibly stable amide
bonds. The DSS1-V5-His recombinant protein was labeled for 1 h
with NHS-PEG4-biotin at a molar ratio of protein/biotin = 1/40 at
25°C room temperature and then moved to 4°C for overnight incu-
bation. The free biotin was removed by overnight dialysis at 4°C cold
room using the Slide-A-Lyzer cassettes (Pierce) with 10-kDa MWCO
against ice-cold 1× PBS. The biotin-labeled DSS1-V5-His was
applied to SDS-PAGE and confirmed by CBB-R250 protein staining
and WB with streptavidin-HRP and antibodies as indicated.
Cell-free protein synthesis
In vitro TNT T7 Quick Coupled Transcription/Translation System
was conducted to synthesize the [35S]-radiolabeled DSS1-myc
fusion protein as described in the instructions (Promega). For each
reaction, 40 μL TNT T7 master mix (T7 RNA polymerase, RNasin
ribonuclease inhibitor, nucleotides, salt, and reticulocyte lysate),
1 μg pcDNA3.1B+/DSS1-myc-His, 2 μL L-[35S]-methionine (20 μCi)
(PelkinElmer, Waltham, MA), and nuclease-free water were added to
a final volume of 50 μL. The cell-free protein synthesis was carried
out at 30°C for 1.5 h. DSS1 and its protein adducts were developed
by autoradiography using a Typhoon 9410 PhosphorImager with the
ImageQuant image analysis software version 5.2 (GE Healthcare).
In vitro assay for DSS1 adduct formation
The total protein lysates (50 μg) extracted from cells were incubated
with DSS1-biotin (20 ng) in a mass ratio of 2500:1. The assay for
DSS1 conjugation to its target proteins was performed overnight at
4°C with rotation in the presence of ATP and Bortezomib (20 μmol/L).
The reaction was stopped by an addition of equal volume of 2× SDS
sample loading buffer followed by incubation for 10 min at 95°C. The
DSS1-protein adduct assay was analyzed by SDS-PAGE and then
detected with strepavidin-HRP at 1:3000.
Cell cultures and UVB irradiation
HEK293F (Life Technologies) and RetroPackTM PT-67 cell lines
(Clontech) were cultured in the Dulbecco’s modified Eagle’s medium
(D-MEM) supplementedwith 10% fetal bovine serum (FBS), 2mmol/L
glutamine, 100 units/mL penicillin, 100 μg/mL streptomycin sulfate,
and1mmol/L sodiumpyruvate (LifeTechnologies).HeLacells (ATCC)
weremaintained in Eagle’s minimum essential medium (E-MEM) with
10% FBS. The cell lines grown at 37°C Forma Water-Jacketed CO2
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incubator (Thermo Fisher Scientific Inc., Waltham, MA) with a
humidified 5% CO2/95% air were free of mycoplasma infection.
HEK293F and HeLa stable cell clones or transiently transfected
HEK293F cells were exposed to UVB radiation, as described previ-
ously (Kim et al., 2010). For UVB radiation studies, the USHIO
G15T8E midrange lamp bulbs with a peak emission at 306 nm were
used. The fluence rate was measured with an IL1400A radiometer/
photometer coupled to a SEL240/UVB-1/TD detector (International
Light inc., Newburyport, MA).
Immunoprecipitation and Western blotting
The cells were washed once with 1× PBS and re-suspended in ice-
cold ATP lysis buffer consisting of 50 mmol/L NaH2PO4, 100 mmol/L
NaCl, 10% glycerol, 5 mmol/L ATP, 5 mmol/L MgCl2, 0.5% Nonidet
P40, 1 mmol/L DTT, 1× protease inhibitor (EDTA-free), and 20 μmol/L
proteasome inhibitor Bortezomib (Lee et al., 2010). Cells were next
disrupted by using Dounce homogenizer (Wheaton, Millville, NJ) for
25 strokes and gently rocked on an orbital shaker at 4°C cold room for
15 min to lyze cells thoroughly. The total protein lysates were centri-
fuged at 14,000 g for 15 min at 4°C. The protein concentration was
determined by BCA (Pierce). The proteins were pulled down by
immunoprecipitation (IP), separated by SDS-PAGE, and then trans-
ferred onto the Hybond-ECL nitrocellulose membranes (GE Health-
care). The membrane was probed with the primary antibodies,
detected using the HRP-conjugated secondary antibodies (1:3000)
(GE Healthcare) and enhanced chemiluminescence (ECL) (GE
Healthcare). Themembrane was stripped and re-hybridized with anti-
actin antibody as an equal loading control.
Identification of the DSS1-protein adducts by mass spectrometry
The potential candidates of DSS1-protein adducts were identified by
interrogating the MS and MS/MS, and analyzed using SEQUEST
against NCBI human protein database, as described previously
(Deterding et al., 2000). The MS results were filtered, sorted, and
displayed using the Bioworks 3.2 at the Proteomic Core Facil-
ity Center in the Institute of Biophysics, Chinese Academy of Sci-
ences, Beijing, China.
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enhanced chemiluminescence; E-MEM, Eagle’s minimum essential
medium; ER, endoplasmic reticulum; FBS, fetal bovine serum; HRP,
horseradish peroxidase; HTBH, His×6-TEV cleavage site-
biotinylated signal peptide sequence-His×6; IP,
immunoprecipitation; IR, ionizing radiation; αLA, α-lipoic acid;
NAC, N-acetylcysteine; NEM, N-ethylmaleimide; NHS, N-
hydroxysuccinimide ester; PAM, PCI associated module; PCI,
proteasome, COP9 signalosome, and eIF3; PCID2, PCI domain
containing protein 2; PCR, polymerase chain reaction; redox,
oxidation-reduction; RNS, reactive nitrogen species; ROS, reactive
oxygen species; SHFM1, split hand/split foot malformation type 1;
TEV, tobacco etch virus; UPS, ubiquitin/proteasome system; USP2,
ubiquitin specific protease 2; UV, ultraviolet; Vit C, Vitamin C; WB,
Western blotting.
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